Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

@article{Ratziu2006DiagnosticVO,
  title={Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease},
  author={Vlad Ratziu and Julien Massard and Fr{\'e}d{\'e}ric Charlotte and Djamila Messous and Françoise Imbert-Bismut and Luninita Bonyhay and Mohamed Tahiri and M. J. Munteanu and Dominique Thabut and Jean françois D. Cadranel and Brigitte le Bail and Victor de Ledinghen and Thierry Poynard},
  journal={BMC Gastroenterology},
  year={2006},
  volume={6},
  pages={6 - 6}
}
BACKGROUND Liver biopsy is considered as the gold standard for assessing non-alcoholic fatty liver disease (NAFLD) histologic lesions. The aim of this study was to determine the diagnostic utility of non-invasive markers of fibrosis, validated in chronic viral hepatitis and alcoholic liver disease (FibroTest, FT), in patients with NAFLD. METHODS 170 patients with suspected NAFLD were prospectively included in a reference center (Group 1), 97 in a multicenter study (Group 2) and 954 blood… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS